{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Deerfield",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA217455"
        ],
        "brand_name": [
          "REGADENOSON"
        ],
        "generic_name": [
          "REGADENOSON"
        ],
        "manufacturer_name": [
          "Baxter Healthcare Corporation"
        ],
        "product_ndc": [
          "36000-364"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "REGADENOSON"
        ],
        "spl_id": [
          "af34327b-48b9-4544-b9ef-4685a261a71e"
        ],
        "spl_set_id": [
          "a81d66a7-b714-439e-ad7b-c7caf9d6f3b8"
        ],
        "package_ndc": [
          "36000-364-01"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0336000364010"
        ],
        "nui": [
          "N0000178375",
          "N0000175788"
        ],
        "pharm_class_epc": [
          "Adenosine Receptor Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Adenosine Receptor Agonists [MoA]"
        ],
        "unii": [
          "2XLN4Y044H"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95664",
      "recalling_firm": "Baxter Healthcare Corporation",
      "address_1": "1 Baxter Pkwy",
      "address_2": "N/A",
      "postal_code": "60015-4625",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the USA",
      "recall_number": "D-0039-2025",
      "product_description": "Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015.  NDC: 36000-364-01",
      "product_quantity": "60,594 units",
      "reason_for_recall": "Labeling: Missing Label",
      "recall_initiation_date": "20241030",
      "center_classification_date": "20241106",
      "report_date": "20241113",
      "code_info": "Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025",
      "more_code_info": ""
    }
  ]
}